Semicarbazones having CNS activity and pharmaceutical preparations
containing same
    2.
    发明授权
    Semicarbazones having CNS activity and pharmaceutical preparations containing same 失效
    具有CNS活性的氨基脲类和含有它们的药物制剂

    公开(公告)号:US5741818A

    公开(公告)日:1998-04-21

    申请号:US475313

    申请日:1995-06-07

    CPC分类号: C07C281/14

    摘要: A compound of general formula I below useful as an anticonvulsant for disorders of the central nervous system: ##STR1## wherein: R.sup.1, R.sup.2, R.sup.3 and R.sup.4 may be the same or different and each represents a hydrogen or halogen atom, or a C.sub.1-9 alkyl, C.sub.3-9 cycloalkyl, cyano, C.sub.1-9 alkoxy or C.sub.6-10 aryloxy group; R.sup.5 represents a hydrogen atom or a C.sub.1-9 alkyl, C.sub.3-9 cycloalkyl or C.sub.6-10 aryl group; and X is oxygen or sulfur; or a pharmaceutically-acceptable salt thereof. The compound may be adimistered orally for treating convulsions in humans or animals.

    摘要翻译: 可用作中枢神经系统疾病的抗惊厥药的下式通式I的化合物:其中:R1,R2,R3和R4可以相同或不同,各自表示氢或卤素原子,或C1- 烷基,C3-9环烷基,氰基,C1-9烷氧基或C6-10芳氧基; R5表示氢原子或C1-9烷基,C3-9环烷基或C6-10芳基; X为氧或硫; 或其药学上可接受的盐。 该化合物可以口服给药以治疗人或动物的抽搐。